Sepsis patients with first and second-hit infections show different outcomes depending on the causative organism

Frontiers in Microbiology

Volumn 7, Issue FEB, 2016, Pages

  Morgan, Matt P ^a,b   Szakmany, Tamas ^a,c   Power, Sarah G ^d   Olaniyi, Patrick ^e   Hall, Judith E ^a   Rowan, Kathy ^d   Eberl, Matthias ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^c Hamad Medical Coorporation Doha Qatar   (United Kingdom)

^d King's College London   (United Kingdom)

^e SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Bacterial infections; Gram negative bacterial infections; Gram positive bacterial infections; Intensive care; Sepsis

Indexed keywords

ACINETOBACTER; ADULT; ARTICLE; BACTEREMIA; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; PSEUDOMONAS; RETROSPECTIVE STUDY; SECONDARY INFECTION; SERRATIA; STAPHYLOCOCCUS AUREUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VANCOMYCIN RESISTANT ENTEROCOCCUS; YEAST;

EID: 84962184026     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00207     Document Type: Article

References (33)

1. Agnese, D. M., Calvano, J. E., Hahm, S. J., Coyle, S. M., Corbett, S. A., Calvano, S. E., et al. (2002). Human Toll-Like Receptor 4 Mutations but Not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186, 1522-1525. doi: 10.1086/344893
2. Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., and Pinsky, M. R. (2001). Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310. doi: 10.1097/00003246-200107000-00002
3. Ani, C., Farshidpanah, S., Bellinghausen Stewart, A., and Nguyen, H. B. (2015). Variations in organism-specific severe sepsis mortality in the United States: 1999-2008. Crit. Care Med. 43, 65-77. doi: 10.1097/CCM.0000000000000555
4. Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., et al. (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 101, 1644-1655.
5. Bryce, J., Boschi-Pinto, C., Shibuya, K., and Black, R. E. (2005). WHO estimates of the causes of death in children. Lancet 365, 1147-1152. doi: 10.1016/S0140-6736(05)71877-8
6. Cain, D. J., del Arroyo, A. G., and Ackland, G. L. (2015). Man is the new mouse: Elective surgery as a key translational model for multi-organ dysfunction and sepsis. J. Intens. Care Soc. 16, 154-163. doi: 10.1177/1751143714564826
7. Cavaillon, J.-M., and Adib-Conquy, M. (2006). Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care. 10, 233. doi: 10.1186/cc5055
8. Davey, M. S., Morgan, M. P., Liuzzi, A. R., Tyler, C. J., Khan, M. W. A., Szakmany, T., et al. (2014). Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J. Immunol. 193, 3704-3716. doi: 10.4049/jimmunol.1401018
9. De Waele, J., Lipman, J., Sakr, Y., Marshall, J. C., Vanhems, P., Barrera Groba, C., et al. (2014). Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome. BMC Infect. Dis. 14:420. doi: 10.1186/1471-2334-14-420
10. Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., et al. (2013). Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit. Care Med. 41, 580-637. doi: 10.1097/ccm.0b013e31827e83af
11. Escoll, P., del Fresno, C., Garciìa, L., Vallés, G., Lendiìnez, M. J., Arnalich, F., et al. (2003). Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem. Biophys. Res. Commun. 311, 465-472. doi: 10.1016/j.bbrc.2003.10.019
12. Gaieski, D. F., Mikkelsen, M. E., Band, R. A., Pines, J. M., Massone, R., Furia, F. F., et al. (2010). Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit. Care Med. 38, 1045-1053. doi: 10.1097/CCM.0b013e3181cc4824
13. Grimaldi, D., Le Bourhis, L., Sauneuf, B., Dechartres, A., Rousseau, C., Ouaaz, F., et al. (2014). Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intens. Care Med. 40, 192-201. doi: 10.1007/s00134-013-3163-x
14. Heginbothom, M., Howe, R., McArtney, B., Parry-Jones, J., Smithies, M., and Szakmany, T. (2013). The Microbiology of Severe Sepsis. Cardiff: Public Health Wales. Available online at: http://www.wales.nhs.uk/sites3/page.cfm?orgId=457pid=28906
15. Hotchkiss, R. S., Monneret, G., and Payen, D. (2013). Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 13, 260-268. doi: 10.1016/S1473-3099(13)70001-X
16. Labelle, A., Juang, P., Reichley, R., Micek, S., Hoffmann, J., Hoban, A., et al. (2012). The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment. Crit. Care Med. 40, 2016-2021. doi: 10.1097/CCM.0b013e318250aa72
17. Leligdowicz, A., Dodek, P. M., Norena, M., Wong, H., Kumar, A., and Kumar, A. (2014). Association between source of infection and hospital mortality in patients who have septic shock. Am. J. Res. Crit. Care Med. 189, 1204-1213. doi: 10.1164/rccm.201310-1875OC
18. Longo, C. J., Heyland, D. K., Fisher, H. N., Fowler, R. A., Martin, C. M., and Day, A. G. (2007). A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care. Crit. Care. 11, R128. doi: 10.1186/cc6195
19. Lynn, L. A. (2014). The diagnosis of sepsis revisited-a challenge for young medical scientists in the 21st century. Patient Saf. Surg. 8:1. doi: 10.1186/1754-9493-8-1
20. Mansur, A., Gruben von, L., Popov, A. F., Steinau, M., Bergmann, I., Ross, D., et al. (2014). The regulatory toll-like receptor 4 genetic polymorphism rs11536889 is associated with renal, coagulation and hepatic organ failure in sepsis patients. J. Transl. Med. 12:177. doi: 10.1186/1479-5876-12-177
21. McPherson, D., Griffiths, C., Williams, M., Baker, A., Klodawski, E., Jacobson, B., et al. (2013). Sepsis-associated mortality in England: an analysis of multiple cause of death data from 2001 to 2010. BMJ Open. 3:e002586. doi: 10.1136/bmjopen-2013-002586
22. Micek, S., Johnson, M. T., Reichley, R., and Kollef, M. H. (2012). An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis. BMC Infect. Dis. 12:56. doi: 10.1186/1471-2334-12-56
23. Newton, S., Cunningham, J., and Dobbin, J. (2014). Sepsis and the NHS. All-Party Parliamentary Group on Sepsis. Available online at: http://sepsisappg.com/wp-content/uploads/2014/02/FINAL_Sepsis_Report_web.pdf
24. Opal, S. M., and Cohen, J. (1999). Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit. Care Med. 27, 1608-1616.
25. Porta, C., Rimoldi, M., Raes, G., Brys, L., Ghezzi, P., Di Liberto, D., et al. (2009). Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB. Proc. Natl. Acad. Sci. U.S.A. 106, 14978-14983. doi: 10.1073/pnas.0809784106
26. Ramachandran, G. (2014). Gram-positive and gram-negative bacterial toxins in sepsis: a brief review. Virulence 5, 213-218. doi: 10.4161/viru.27024
27. Schmid, A., Burchardi, H., Clouth, J., and Schneider, H. (2002). Burden of illness imposed by severe sepsis in Germany. Eur. J. Health Econ. 3, 77-82. doi: 10.1007/s10198-002-0095-8
28. Stevenson, E. K., Rubenstein, A. R., Radin, G. T., Wiener, R. S., and Walkey, A. J. (2014). Two decades of mortality trends among patients with severe sepsis. Crit. Care Med. 42, 625-631. doi: 10.1097/CCM.0000000000000026
29. Trusheim, M. R., Berndt, E. R., and Douglas, F. L. (2007). Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat. Rev. Drug Discov. 6, 287-293. doi: 10.1038/nrd2251
30. Vincent, J. L., Bihari, D. J., Suter, P. M., Bruining, H. A., White, J., Nicolas-Chanoin, M. H., et al. (1995). The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274, 639-644.
31. Vincent, J.-L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C. D., et al. (2009). International study of the prevalence and outcomes of infection in intensive care units. JAMA 302, 2323-2329. doi: 10.1001/jama.2009.1754
32. Vincent, J.-L., Sakr, Y., Sprung, C. L., Ranieri, V. M., Reinhart, K., Gerlach, H., et al. (2006). Sepsis in European intensive care units: results of the SOAP study. Crit. Care Med. 34, 344-353. doi: 10.1097/01.CCM.0000194725.48928.3A
33. Zilberberg, M. D., Shorr, A. F., Micek, S. T., Vazquez-Guillamet, C., and Kollef, M. H. (2014). Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit. Care 18, 596. doi: 10.1186/s13054-014-0596-8